Synergy CHC Corp. Announces Jeffrey Kadanoff Joins as CFO
Westbrook, Maine, October 15, 2017– Synergy CHC Corp (“Synergy”) (OTCQB: SNYR), a consumer health care & beauty company, announces the appointment of Jeffrey Kadanoff as its Chief Financial Officer effective November 1, 2017. Mr. Kadanoff’s appointment strengthens Synergy’s ability to raise financing, and supports the company’s growth organically through corporate initiatives and by further acquisition.
“I have worked closely in partnership with Jeffrey over the last two and half years, and have seen firsthand how he can add value to Synergy. We are delighted to welcome Jeffrey to the leadership team.” said Jack Ross, Chairman and CEO of Synergy.
“I am excited to join Jack and the rest of the very capable team at Synergy. I have witnessed their impressive growth beginning with the acquisition of FOCUSfactor and continuing with the development of The Synergy Effect, and I look forward to sustaining that trend,” said Jeffrey Kadanoff.
Jonathan Ross Goodman, CEO of Knight said, “We are thrilled that Jeffrey has chosen to stay within our noble family where he can continue to add GUD value to Knight through our various partnerships and equity stake in Synergy.”
Mr. Kadanoff was the Chief Financial Officer for Knight Therapeutics Inc. (“Knight”) (TSX: GUD), a leading Canadian specialty pharmaceutical company, from its inception as a publicly listed company in February 2014 until October 2017. Prior to joining Knight, Mr. Kadanoff was a Principal with Bain & Company where he served as a strategy consultant for 14 years. Additionally, Mr. Kadanoff was Vice President-Strategic Planning and Development at Reitmans. Mr. Kadanoff holds a B. Eng. with Distinction in Chemical Engineering and a Minor in Management from McGill University, and an MBA with Distinction from INSEAD.
While under Mr. Kadanoff’s leadership as CFO, Knight’s market capitalization increased from under $100 million to over $1 billion. Mr. Kadanoff led Knight from the TSX-V to an uplisting on the TSX to ultimately being included on the S&P/TSX Composite Index. Mr. Kadanoff’s tenure at Knight included five equity raises in under three years all at increasing valuations for net proceeds of over $500 million. Additionally, Mr. Kadanoff arrives at Synergy with deep knowledge in the company’s business model and brands given his role on behalf of Knight in providing financing for the company’s major acquisitions and leading the business relationship with Synergy on behalf of Knight.
About Synergy CHC Corp.
Synergy CHC Corp. is a consumer health care & beauty company that is in the process of building a portfolio of bestin-
class consumer product brands. Synergy’s strategy is to grow its portfolio both organically and by further
acquisition. Synergy’s diversified portfolio now includes FOCUSFactor™, Flat Tummy Tea™, Per-fékt Beauty™,
Sneaky Vaunt™, The Queen Pegasus™, Neuragen™, and Hand MD™. For more information, please visit
Flat Tummy Co®
Flat Tummy Co’s uniquely formulated two-step herbal detox tea works to naturally help speed metabolism, boost energy and reduce bloating to flatten your tummy. It’s currently sold exclusively online to a global, 20-30 year old female, predominantly American market.
Since being founded in 2013, Flat Tummy Co has grown rapidly, largely attributed to the strength of their branding and their innovative and effective use of social media. Their secret is a very specific process and ROI based algorithm used on various online platforms. To date, Flat Tummy Co has built a targeted social media following of over 1,392,000, many of whom are now customers.
FOCUSfactor is sold at America’s leading retailers such as Costco, Sam’s Club, Wal-Mart, BJ’s Walgreens, CVS and The Vitamin Shoppe. FOCUSfactor, America’s leading brain health supplement, is a nutritional supplement that includes a proprietary blend of brain supporting vitamins, minerals, antioxidants and other nutrients. In December 2012, the United States Patent and Trademark Office issued US Patent 8,329,227 covering FOCUSfactor’s proprietary formulation “for enhanced mental function.” The issuance of the patent marked one of the few times a patent has been issued for a nationally branded nutritional supplement. FOCUSfactor is clinically tested with results demonstrating improvements in focus, concentration and memory in healthy adults. www.focusfactor.com
Per-fékt Beauty is Synergy’s newest brand that was acquired in June of 2017. Per-fékt Beauty markets and sells a specialized range of beauty products (makeup, skin-care & body) via retailers and online through social media channels.
Per-fékt Beauty is well established in the beauty retail space (Sephora and Ulta), opening up an exciting retail opportunity for the rest of our products in that industry. Even more exciting is the potential to apply the same ROI based algorithm that Flat Tummy Co uses and is currently being used by The Synergy Effect on various online marketing platforms — what could be more per-fekt?
Sneaky Vaunt is one of Synergy’s newest brands that just launched in March of 2017. Sneaky Vaunt markets and sells a backless, strapless, stick on, push up bra exclusively online through social media channels.
Sneaky Vaunt is being marketed on the same ROI based algorithm that Flat Tummy Co uses and is currently being used by The Synergy Effect on various online marketing platforms. In just over three months, Sneaky Vaunt has built a targeted social media following of over 385,000 on Instagram.
Neuragen® is a topical product that works directly at the site of the pain as opposed to oral products. Neuragen® reduces the spontaneous firing of damaged peripheral nerves. By calming these firings at the source, Neuragen® is clinically shown to reduce shooting and burning pains quickly and without the side effects of orally taken medications. This is in part due to the small lipophilic molecules found in Neuragen® which rapidly carry the active ingredients through the rough outer layer of the skin to the site of the pain. Neuragen® is available over the counter in most local pharmacies either in the diabetic section or the analgesic (pain) section. For more information, please visit www.neuragen.com.
Hand MD is the world’s first anti-aging skincare line formulated specifically for the hands. Hands reveal a woman’s true age and the rejuvenation of the hand has become women’s #1 aging concern. Developed by Kara Harshbarger and renowned celebrity dermatologist Dr. Alex Khadavi, Hand MD’s extensive clinical trials show significant improvement in the appearance of fine lines and wrinkles, skin hydration, hyper-pigmentation and radiance. HAND MD launched on QVC and sold out in an astonishing 5 minutes. www.hand-md.com.
The Synergy Effect®
The Synergy Effect is Synergy’s fast-growth online marketing platform, a growth engine built to grow brands exponentially online. Launched in 2017, The Synergy Effect powers Synergy’s brands online, driving revenue using best-in-class digital strategy and its proprietary ROI algorithm. Already boasting success stories including Flat Tummy Co and Sneaky Vaunt, both of which have experienced unprecedented growth in digital and social media, The Synergy Effect will spend the upcoming year further unlocking the huge online growth potential within Synergy’s existing portfolio of brands, as well as brands acquired by Synergy.
More information on The Synergy Effect can be found at www.thesynergyeffect.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties. All statements, other than statements of historical facts, regarding management’s expectations, beliefs, goals, plans or Synergy’s prospects should be considered forward-looking. Readers are cautioned that actual results may differ materially from projections or estimates due to a variety of important factors, including: Synergy’s ability to integrate any new products into its current operations; the risks and uncertainties associated with Synergy’s ability to manage its cash resources; obtaining additional financing to support Synergy’s operations; Synergy’s dependence on third parties for its research and development, manufacturing and distribution functions; Synergy’s dependence on its license relationships; protecting the intellectual property developed by or licensed to Synergy; and Synergy’s ability to build its operations to support its business strategy and promote its products. These and other risks are described in greater detail in Synergy’s filings with the SEC, copies of which are available free of charge at the SEC’s website (www.sec.gov) or upon request from Synergy. Synergy may not actually achieve the goals or plans described in its forward-looking statements, and investors should not place undue reliance on these statements. Synergy assumes no obligation and does not intend to update these forward-looking statements, except as required by law.